ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.038,41
0,40%
Dow Jones
38.070,18
0,44%
Euro vs US Dollar
1,07094
-0,08%
Bitcoin
59.036,19
1,37%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cymabay Therapeutics Inc (CBAY)

  7. Cymabay Therapeutics Inc (CBAY) News

CBAY Cymabay Therapeutics Inc

32,48
0,00 (0,00%)
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cymabay Therapeutics Inc CBAY NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 32,48 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
32,48
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.3.202414:18BWGilead Sciences Announces Completion of Acquisition of..
11.3.202414:14EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
07.3.202422:35EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
28.2.202423:01EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
23.2.202412:25EDGAR2Form SC 14D9 - Solicitation, recommendation statements
16.2.202423:14EDGAR2Form SC14D9C - Written communication relating to third party..
15.2.202422:15EDGAR2Form 144 - Report of proposed sale of securities
15.2.202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202418:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202415:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202423:29EDGAR2Form SC14D9C - Written communication relating to third party..
12.2.202422:06EDGAR2Form 144 - Report of proposed sale of securities
12.2.202419:43PRNUSKuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to..
12.2.202414:45EDGAR2Form SC14D9C - Written communication relating to third party..
12.2.202414:42EDGAR2Form 8-K - Current report
06.2.202423:38EDGAR2Form 144 - Report of proposed sale of securities
01.2.202423:00EDGAR2Form 144 - Report of proposed sale of securities
31.1.202400:33EDGAR2Form 144 - Report of proposed sale of securities
29.1.202423:59EDGAR2Form 144 - Report of proposed sale of securities
27.1.202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202423:21EDGAR2Form 144 - Report of proposed sale of securities
26.1.202422:06EDGAR2Form 8-K - Current report
23.1.202400:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202422:33EDGAR2Form 144 - Report of proposed sale of securities
20.1.202401:15EDGAR2Form 144 - Report of proposed sale of securities
19.1.202422:44EDGAR2Form 144 - Report of proposed sale of securities
18.1.202422:39EDGAR2Form 144 - Report of proposed sale of securities
17.1.202422:54EDGAR2Form 144 - Report of proposed sale of securities
17.1.202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202422:24EDGAR2Form 144 - Report of proposed sale of securities
16.1.202422:23EDGAR2Form 144 - Report of proposed sale of securities
11.1.202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:11EDGAR2Form 144 - Report of proposed sale of securities
03.1.202422:50EDGAR2Form 144 - Report of proposed sale of securities
21.12.202322:01EDGAR2Form 8-K - Current report
19.12.202302:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:07EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
CBAY
Cymabay Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten